NEFL and Alzheimer disease: Specifically, using the Single Molecule Array (SIMOA) technology (Quanterix, USA), the authors detected no statistically significant differences in salivary NfL concentrations across the diagnostic groups comprising healthy controls, MCI, AD, and non‐AD.